Please read our letter by clicking on the icon
to the right, regarding information about COVID-19
For a video explaining the safety and efficacy of
the four Health Canada approved vaccines, click on
the button to the right.
If you have any questions regarding blood clots and vaccines, please read this publication by Thrombosis Canada.
June 18th, 2021 -
Ontario has now decided to hold all first doses of Astra Zeneca brand vaccine. At this time, anyone who received a first dose is eligible to receive either a second dose of the same vaccine, or one of the mRNA vaccines at the 8-12 week mark. For a helpful article regarding the Astra Zeneca vaccine, please consult the following link.
For those of you who received the Astra Zeneca vaccine at our clinic the week of May 5th, we are still talking to Ottawa Public Health about procuring second dose shots for the first week of July. This will depend on vaccine availability and recommendations from NACI and Ontario's chief medical officer of health. We may be in contact with you to see if you would like your name to be on a call-back list, or alternatively you may call us or fill out the contact form. You may also decide to have your second dose at a participating pharmacy if the opportunity arises.
Who can receive the vaccine?
Eligible people aged 12+ may receive their vaccine at a city-based facility, pop-up clinic, or in select pharmacies.
Based on the province’s COVID-19 Vaccination Distribution Plan, Ontario is in Phase 3. Vaccine delivery in each region will vary.
It is currently recommended to space apart any other vaccines by at least 2 weeks from your COVID-19 vaccine. The majority of Canadians will receive their second dose at the 16-week mark.
Second Dose Interval Exceptions
Ontario is now offering shortened interval dosing to adults over age 70 and essential health care workers. There are a limited number of exceptions to the 16-week interval between the first and second vaccine dose. In these cases the interval should be maintained at the product monograph recommended interval for patients: (1) with malignant hematologic disorders on immunocompromising therapy (chemotherapy, targeted therapies, immunotherapy), (2) nonhematologic malignant solid tumors on immunocompromising therapy (chemotherapy, targeted therapies, immunotherapy); (3) transplant recipients (including solid organ transplants and hematopoietic stem cell transplants), given evidence of reduced immune response to vaccination in these individuals. Upon request, we would issue a letter to confirm that you are eligible to get a second dose appointment at the monograph interval, identifying one of the above reasons for the exception. The letter should be presented at both the first and second appointments for the vaccine. An earlier second dose can be arranged by calling this number: 1-888-999-6488.
June 18th, 2021 - We still have regular dose quadrivalent vaccines (against four strains) and high dose trivalent vaccines (against three strains), the latter is recommended for patients aged 65 and over. Infants and children aged 6 months to 9 years who have never had the flu vaccine would require 2 doses 4 weeks apart.
You may call the office to obtain an appointment. We would request that you come prepared with a short sleeved top for efficient inoculation. It is no longer required to wait for 15 minutes following the shot, and you may leave the clinic as soon as it is done. Pharmacies will not administer vaccines to children under age 5 - one must visit the medical office or a public health community clinic. Please click on the Ottawa Public Health link below for the list of pharmacies and community clinics offering the flu vaccines (under heading "Public Health Topics", and subheading "Immunizations".)
June 18th, 2021 - We are trying to maintain childhood vaccines as close to the regular schedule as possible and hold in-person appointments for these primary vaccines in high priority.
We are booking Shingrix, Prevnar, and other elective adult vaccines on a case-by-case basis. During the current lockdown, we are encouraging everyone to delay these nonurgent vaccines until a) you obtain both your COVID-19 vaccines, and b) it is safer to be in indoor spaces. The benefit you might gain from obtaining one of these vaccines should be weighed against the risk of COVID-19 transmission indoors.